Investors reacted to insider buying, clinical trial updates, and strategic business shifts that happened in the week ended March 21, 2025.
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.